| Description | Miglustat-d9 (hydrochloride), a deuterium-labeled variant of Miglustat (hydrochloride), functions as a glucosylceramide synthase inhibitor. Its primary application is in the treatment of Type I Gaucher disease (GD1) [1][2]. |
| molecular weight | 264.79 |
| Molecular formula | C10H13D9ClNO4 |
| CAS | 1883545-57-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years | Shipping with blue ice. |